Company Information
- Type:
- Company
- Country:
- United States of America
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 19 January 2009 Letter of Commitment
Financial Information
Non-Financial Information
Principles and Global Goals Addressed in their most recent CoP
Next Communication on Progress (CoP) due on:
Communication On Progress
Published On | Title | Level |
---|---|---|
2022-09-18 | Communication on Progress | Active |
2021-09-16 | Merck 2020/2021 ESG Progress Report | Active |
2020-10-15 | 2019/2020 Corporate Responsibility Report | Active |
2019-10-09 | Communication on Progress | Active |
2018-10-09 | Communication on Progress | Active |
2017-11-21 | Communication on Progress | Active |
14-Sep-2017 | Grace Letter | Not applicable |
2016-09-20 | Communication on Progress | Active |
2015-10-05 | Communication on Progress | Active |
2015-07-12 | Grace Letter | Not applicable |
2014-08-07 | 2013 Merck Corporate Responsibility Report | Active |
2013-08-07 | Merck 2012 Corporate Responsibility Report | Active |
2012-09-13 | Communication on Progress | Learner |
2011-09-30 | 2011 Communication on Progress | Learner |
2010-10-28 | 2010 Communication on Progress | Not applicable |
2010-09-03 | Grace Letter | Not applicable |
2009-10-02 | 2008 Corporate Responsibility Report: Advancing the Dialogue Toward a Healthier Future | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.